Ticker Scorecard - RAPT Basics Company: RAPT Therapeutics, Inc. IPO Date: October 28, 2019 Sector: Healthcare Industry: Biotech Market Cap: $165.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.75 | 3.89% Avg Daily Range (30 D): $0.04 | 2.91% Avg Daily Range (90 D): $0.07 | 4.60% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .83M Avg Daily Volume (90 D): 2.08M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 207 Avg Trade Size (Sh.) (90 D): 264 Institutional Trades Total Inst.Trades: 1,050 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $2.4M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $1.39M Avg Closing Trade (90 D): $1.39M Avg Closing Volume: 73.74K     News Jan 6, 2025 @ 1:00 PM RAPT Therapeutics Names Lori Lyons-Williams Cha... Source: Rapt Therapeutics, Inc. Jul 19, 2024 @ 2:00 PM Agenus (AGEN) Tanks on Colorectal Cancer Study Int... Source: N/A Jul 17, 2024 @ 2:01 PM Arcutis (ARQT) Stock Rises 31% in the Past Month: ... Source: Zacks Equity Research Jul 16, 2024 @ 2:30 PM Lisata (LSTA) Stock Rallies More Than 30% YTD: Her... Source: N/A Jul 10, 2024 @ 1:01 PM Athira (ATHA) Completes Dosing in Alzheimer's Stud... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.47 $-.71 $-.79 Diluted EPS $-.47 $-.71 $-.79 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -18.43M $ -27.66M $ -30.52M Operating Income / Loss $ -19.79M $ -29.33M $ -32.52M Cost of Revenue $ $ $ Net Cash Flow $ .82M $ -8.24M $ -2.16M PE Ratio